Erisyon Inc, based in Brooklyn, NY, is a pioneering company at the forefront of decoding nature for human health and beyond. Their groundbreaking technology, Fluorosequencing, offers single-molecule protein sequencing with unparalleled sensitivity, resolution, and absolute quantification, revolutionizing disease detection, treatment, and tracking.
Developed by a team of multi-disciplinary scientists at the University of Texas Austin, Erisyon's Fluorosequencing promises earlier disease detection and treatment, leading to faster breakthroughs and improved patient outcomes. With their expertise in next-generation DNA sequencing applied to proteomics, Erisyon is leading the way in transforming biological research and advancing the field of single-molecule peptide sequencing.
Generated from the website